NDC 59148-038

Rexulti

Brexpiprazole

Rexulti is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Otsuka America Pharmaceutical, Inc.. The primary component is Brexpiprazole.

• Product ID: 59148-038_31903d3f-5e72-4215-aeeb-71f10e424cf1
• NDC: 59148-038
• Product Type: Human Prescription Drug
• Proprietary Name: Rexulti
• Generic Name: Brexpiprazole
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2015-07-10
• Marketing Category: NDA / NDA
• Application Number: NDA205422
• Labeler Name: Otsuka America Pharmaceutical, Inc.
• Substance Name: BREXPIPRAZOLE
• Active Ingredient Strength: 2 mg/1
• Pharm Classes: Atypical Antipsychotic [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 59148-038-13

1 BOTTLE in 1 CARTON (59148-038-13) > 30 TABLET in 1 BOTTLE

• Marketing Start Date: 2015-07-10
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 59148-038-13 [59148003813]

REXULTI TABLET

• Marketing Category: NDA
• Application Number: NDA205422
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2015-07-10

Drug Details

Active Ingredients

Ingredient	Strength
BREXPIPRAZOLE	2 mg/1

OpenFDA Data

• SPL SET ID: 2d301358-6291-4ec1-bd87-37b4ad9bd850
• Manufacturer:
  • Otsuka America Pharmaceutical, Inc.
• UNII:
  • 2J3YBM1K8C
• RxNorm Concept Unique ID - RxCUI:
  • 1658343
  • 1658341
  • 1658345
  • 1658337
  • 1658325
  • 1658335
  • 1658327
  • 1658333
  • 1658331
  • 1658319
  • 1658329
  • 1658339

Pharmacological Class

• Atypical Antipsychotic [EPC]

Medicade Reported Pricing

59148003813 REXULTI 2 MG TABLET

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Rexulti" or generic name "Brexpiprazole"

NDC	Brand Name	Generic Name
59148-035	Rexulti	brexpiprazole
59148-036	Rexulti	brexpiprazole
59148-037	Rexulti	brexpiprazole
59148-038	Rexulti	brexpiprazole
59148-039	Rexulti	brexpiprazole
59148-040	REXULTI	REXULTI